Acceptability of Human Papillomavirus Self-Sampling Among a National Sample of Women in the United States.

Q2 Biochemistry, Genetics and Molecular Biology BioResearch Open Access Pub Date : 2019-04-30 eCollection Date: 2019-01-01 DOI:10.1089/biores.2018.0040
Erin Bishop, Mira L Katz, Paul L Reiter
{"title":"Acceptability of Human Papillomavirus Self-Sampling Among a National Sample of Women in the United States.","authors":"Erin Bishop,&nbsp;Mira L Katz,&nbsp;Paul L Reiter","doi":"10.1089/biores.2018.0040","DOIUrl":null,"url":null,"abstract":"<p><p>As human papillomavirus (HPV) self-sampling continues to emerge as a potential cervical cancer screening strategy in the United States, it is necessary to examine women's acceptability of this screening approach. Furthermore, since several HPV self-sampling devices exist, it is important to determine if women's preferences differ by device type. We conducted an online survey in Fall 2017 with a national sample of women (<i>n</i> = 605) ages 21-65 years (the recommended age range for cervical cancer screening). Multivariable linear regression identified correlates of women's willingness to use an HPV self-sample at home. We used repeated measures analysis of variance to determine if preferences differed across four self-sampling devices: Evalyn<sup>®</sup> Brush (Device A), HerSwab<sup>®</sup> (Device B), Catch-All<sup>®</sup> Swab (Device C), and Qvintip<sup>®</sup> (Device D). Most women were willing to use an HPV self-sample at home (mean = 4.03 [possible range: 1-5], standard deviation = 1.09, 72.7% indicated \"probably willing\" or \"definitely willing\"). The most common concerns about self-sampling were related to test accuracy (53.1%) and obtaining the sample incorrectly (51.1%). Women were more willing to use an HPV self-sample at home if they reported greater perceived severity of cervical cancer (<i>β</i> = 0.16), reported an annual income less than $50,000 (<i>β</i> = 0.13), or were a former smoker (<i>β</i> = 0.11). Women were more willing to use Device A (mean = 3.72, 67.6% indicated \"agree\" or \"strongly agree\"), Device C (mean = 3.86, 73.9% indicated \"agree\" or \"strongly agree\"), and Device D (mean = 3.81, 72.1% indicated \"agree\" or \"strongly agree\") than Device B (mean = 3.36, 49.4% indicated \"agree\" or \"strongly agree\"; all <i>p</i> < 0.05). Acceptability of HPV self-sampling as a cervical cancer screening strategy is generally high among women. Future efforts should consider the potential impact that device type may have on women's use of an HPV self-sample at home.</p>","PeriodicalId":9100,"journal":{"name":"BioResearch Open Access","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2019-04-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1089/biores.2018.0040","citationCount":"16","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BioResearch Open Access","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1089/biores.2018.0040","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2019/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Biochemistry, Genetics and Molecular Biology","Score":null,"Total":0}
引用次数: 16

Abstract

As human papillomavirus (HPV) self-sampling continues to emerge as a potential cervical cancer screening strategy in the United States, it is necessary to examine women's acceptability of this screening approach. Furthermore, since several HPV self-sampling devices exist, it is important to determine if women's preferences differ by device type. We conducted an online survey in Fall 2017 with a national sample of women (n = 605) ages 21-65 years (the recommended age range for cervical cancer screening). Multivariable linear regression identified correlates of women's willingness to use an HPV self-sample at home. We used repeated measures analysis of variance to determine if preferences differed across four self-sampling devices: Evalyn® Brush (Device A), HerSwab® (Device B), Catch-All® Swab (Device C), and Qvintip® (Device D). Most women were willing to use an HPV self-sample at home (mean = 4.03 [possible range: 1-5], standard deviation = 1.09, 72.7% indicated "probably willing" or "definitely willing"). The most common concerns about self-sampling were related to test accuracy (53.1%) and obtaining the sample incorrectly (51.1%). Women were more willing to use an HPV self-sample at home if they reported greater perceived severity of cervical cancer (β = 0.16), reported an annual income less than $50,000 (β = 0.13), or were a former smoker (β = 0.11). Women were more willing to use Device A (mean = 3.72, 67.6% indicated "agree" or "strongly agree"), Device C (mean = 3.86, 73.9% indicated "agree" or "strongly agree"), and Device D (mean = 3.81, 72.1% indicated "agree" or "strongly agree") than Device B (mean = 3.36, 49.4% indicated "agree" or "strongly agree"; all p < 0.05). Acceptability of HPV self-sampling as a cervical cancer screening strategy is generally high among women. Future efforts should consider the potential impact that device type may have on women's use of an HPV self-sample at home.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
人乳头瘤病毒自我抽样在美国全国妇女样本中的可接受性
由于人乳头瘤病毒(HPV)自我抽样在美国继续作为一种潜在的宫颈癌筛查策略出现,有必要检查妇女对这种筛查方法的可接受性。此外,由于存在几种HPV自采样设备,确定女性的偏好是否因设备类型而异是很重要的。我们于2017年秋季对全国范围内21-65岁(宫颈癌筛查的推荐年龄范围)的女性(n = 605)进行了一项在线调查。多变量线性回归确定了妇女在家使用HPV自我样本意愿的相关因素。我们使用重复测量方差分析来确定四种自采样设备的偏好是否不同:Evalyn®Brush(设备A), HerSwab®(设备B), Catch-All®拭子(设备C)和Qvintip®(设备D)。大多数女性愿意在家中使用HPV自采样(平均值= 4.03[可能范围:1-5],标准差= 1.09,72.7%表示“可能愿意”或“肯定愿意”)。自采样最常见的问题是测试准确性(53.1%)和获取样本不正确(51.1%)。如果女性报告宫颈癌的严重程度较高(β = 0.16),报告年收入低于50,000美元(β = 0.13),或者曾经吸烟(β = 0.11),则更愿意在家中使用HPV自我样本。女性更愿意使用设备A(平均= 3.72,67.6%表示“同意”或“非常同意”)、设备C(平均= 3.86,73.9%表示“同意”或“非常同意”)和设备D(平均= 3.81,72.1%表示“同意”或“非常同意”),而设备B(平均= 3.36,49.4%表示“同意”或“非常同意”);所有p
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
BioResearch Open Access
BioResearch Open Access Biochemistry, Genetics and Molecular Biology-Biochemistry, Genetics and Molecular Biology (all)
自引率
0.00%
发文量
1
期刊介绍: BioResearch Open Access is a high-quality open access journal providing peer-reviewed research on a broad range of scientific topics, including molecular and cellular biology, tissue engineering, regenerative medicine, stem cells, gene therapy, systems biology, genetics, virology, and neuroscience. The Journal publishes basic science and translational research in the form of original research articles, comprehensive review articles, mini-reviews, rapid communications, brief reports, technology reports, hypothesis articles, perspectives, and letters to the editor.
期刊最新文献
An Innovative Physical Therapy Intervention for Chronic Pain Management and Opioid Reduction Among People Living with HIV. Characterization of Laminins in Healthy Human Aortic Valves and a Modified Decellularized Rat Scaffold. Why Do We Need Serological Tests for Severe Acute Respiratory Syndrome Coronavirus-2 Diagnosis? Immunotherapy for Infarcts: In Vivo Postinfarction Macrophage Modulation Using Intramyocardial Microparticle Delivery of Map4k4 Small Interfering RNA. Comparative Evaluation of the Effects of Consumption of Colombian Agraz (Vaccinium meridionale Swartz) on Insulin Resistance, Antioxidant Capacity, and Markers of Oxidation and Inflammation, Between Men and Women with Metabolic Syndrome.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1